Video Latest - ecancer

New genetic sub-types of breast, ovarian and prostate cancer

Dr Paul Pharoah – University of Cambridge, UK

14 Nov 2012

A national study of cancer patient experiences

Dr Reg Race – Quality Health, Debyshire, UK

14 Nov 2012

The Helico Eradication Aspirin Trial (HEAT)

Prof Chris Hawkey – The University of Nottingham, UK

1 Nov 2012

The ASPree study: ASPirin in Reducing Events in the Elderly

Prof John McNeil – Monash University, Prahran, Australia

1 Nov 2012

Highlights of the 2012 Aspirin Foundation meeting

Nick Henderson – Executive Director, Aspirin Foundation

1 Nov 2012

Effects of aspirin on the progression of cancer

Prof Peter Rothwell – Oxford University, UK

1 Nov 2012

Side effects of treating with aspirin

Prof Peter Elwood – Cardiff University, UK

1 Nov 2012

Recent evidence to support the use of aspirin in the treatment of cancer

Dr Ruth Langley – Medical Research Council, London, UK

1 Nov 2012

Aspirin in cardiovascular disease

Prof Carlo Patrono – Catholic University School of Medicine in Rome, Italy

1 Nov 2012

Effectiveness of PARP inhibitors in ovarian cancer

Prof Jonathan Ledermann - University College London, UK

1 Nov 2012

Phase III HECTOR study: recurring platinum sensitive ovarian cancer

Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg, Germany

31 Oct 2012

GOG 209 study: optimal management of advanced endometrial cancer

Prof David Miller – University of Texas Southwestern Medical Centre, Dallas, USA

31 Oct 2012

Video